Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people
Mario Cruciani, Lewis White(Public Health Wales), Oliver Morton(Western Sydney University), Lena Klingspor(Karolinska University Hospital), J. Peter Donnelly(Baylor College of Medicine), Johan Maertens(Unknown), Brian Jones(University of Glasgow), Rosemary A. Barnes(Innsbruck Medical University), Juergen Loeffler(Augenklinik Universitätsklinikum Würzburg), Carlo Mengoli(University of Padua)
Cited by 76
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
|Clinical Infectious Diseases|2002|2.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k